↓ Skip to main content

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia

Overview of attention for article published in Journal of Translational Medicine, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
148 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
Published in
Journal of Translational Medicine, February 2013
DOI 10.1186/1479-5876-11-31
Pubmed ID
Authors

Hussein Fayyad-Kazan, Nizar Bitar, Mehdi Najar, Philippe Lewalle, Mohammad Fayyad-Kazan, Rabih Badran, Eva Hamade, Ahmad Daher, Nader Hussein, Rim ELDirani, Fadwa Berri, Luc Vanhamme, Arsène Burny, Philippe Martiat, Redouane Rouas, Bassam Badran

Abstract

MicroRNAs (miRNAs) are small (19-22-nt) single-stranded noncoding RNA molecules whose deregulation of expression can contribute to human disease including the multistep processes of carcinogenesis in human. Circulating miRNAs are emerging biomarkers in many diseases and cancers such as type 2 diabetes, pulmonary disease, colorectal cancer, and gastric cancer among others; however, defining a plasma miRNA signature in acute myeloblastic leukemia (AML) that could serve as a biomarker for diagnosis or in the follow-up has not been done yet.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Australia 1 <1%
South Africa 1 <1%
Unknown 108 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 17%
Student > Master 19 17%
Researcher 13 12%
Student > Postgraduate 6 5%
Professor > Associate Professor 6 5%
Other 20 18%
Unknown 28 25%
Readers by discipline Count As %
Medicine and Dentistry 24 22%
Biochemistry, Genetics and Molecular Biology 24 22%
Agricultural and Biological Sciences 20 18%
Chemistry 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 5 5%
Unknown 33 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2013.
All research outputs
#7,424,121
of 22,696,971 outputs
Outputs from Journal of Translational Medicine
#1,230
of 3,966 outputs
Outputs of similar age
#85,312
of 282,966 outputs
Outputs of similar age from Journal of Translational Medicine
#36
of 89 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,966 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,966 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.